Cellectar biosciences inc

Major-Pharmaceuticals

CLRB


100 Campus Drive
Florham Park , NJ 07932

Executive/
Director

Price

  • Last Close
  • $ 1.39
    $ +0.03 2.21 %
    Dec 6, 2024
  • 52-Week High/Low
  • $4.24 - $1.77
  • YTD
  • -49.8%

  • Trading Volume
  • 11,000
  • Market Cap Full
  • $ 17.1M
  • Shares Outstanding
  • 12.3M
    Nov 10, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 0.7% -53.5% 86.1% -17.2% 51.6% -5% -21.8% 11.5% -15.8% 43.7%
Q2 -7.4% 0.6% -28.2% -43.1% -12.8% 4% -26.1% -46% 35.4% 1.8%
Q3 -31.6% -21.2% 2.5% -50% -9.3% 8% -22.3% 740% 35.4% -
Q4 -62.7% -55% -20.4% -52.9% 15.3% 67.5% -28.2% -49.1% -3.2% -
J F M A M J J A S O N D
2024 41.2% 0.3% 1.5% 0.3% - - - - - - - -
2023 -11.1% 2.6% -7.7% 6.3% 2% 25% - -9.2% 49.2% -8.3% 2.1% 12.2%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%-76%-83%12%-89%46%-9%-68%158%62%-50%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.30 0.91 0.24 -2.07 -0.76 -0.42 -0.13 -1 -0.76
Q2 0.30 0.49 0.23 -1.69 -0.46 -0.26 -0.11 -1.22 -0.73
Q3 0.25 0.43 0.26 -1.65 -0.42 -0.15 -0.1 -1.28 -1.21
Q4 - 0.35 34 0.18 -0.2 0.07 -0.94 -0.55 -
A 0.9 2.2 34.7 -5.2 -1.8 -1.8 -4.4 -4.1 -2.7

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 4.8 9.4 50.5 61.1 9.7
Jun 17.4 5.3 9.4 52.7 61.1 9.7
Sep 3.6 9.4 26.6 61.1 6.1 9.7
Dec 4.8 9.4 26.8 61.1 9.4 12.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - - - -
Equity multiplier - - - - 0.2